Skip to content
Velocity Technologies

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Deal Because of Data Concerns

Health funding image
The proposed US financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) spanning five years due to the United States' demand for sensitive biological samples.

This move became public after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesperson has since explained that the US was requesting genetic material for research and commercial gain but was unwilling to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for more negotiations to secure a agreement agreeable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Background

This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the security of Kenyans' medical information.

Since resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had administered aid for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.

According to reports, 16 nations in Africa have to date signed similar agreements, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through US-supported programmes," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.

"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a future pandemic arise."

National Interest and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending systems previously set up via the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.

"This mechanism is designed to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."

These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how subsequent collaboration could be structured in a way that honours the independence and interests of both nations."

Health Experts Response

Medical experts expressed it recognised the official position, but suggested that talks should continue given that a large portion of the country's HIV programmes relied on external financing.

"In cases where technical issues exist, including those relating to data governance or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it said.

The situation emphasises the ongoing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.

KF
By

Kimberly Francis

A tech strategist with over a decade of experience in digital transformation and IT consulting across European markets.

Velocity Technologies

Type to search articles.